Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeremy B. Hayden currently holds 369,770 shares of CYTORI THERAPEUTICS, INC. (CYTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeremy B. Hayden has been a net seller of CYTX stock. They have purchased $10.0K and sold $672.9K worth of shares.
Jeremy B. Hayden's most recent insider trade was on Apr 6, 2026, when they sold 13,761 shares at $3.55 per share.
Jeremy B. Hayden serves as Executive at CYTORI THERAPEUTICS, INC. (CYTX). They have executed 27 insider transactions totaling $682.9K over their tenure at the company.
Jeremy B. Hayden holds the position of Executive at CYTORI THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jeremy B. Hayden has shown a selling trading pattern, with $10.0K in total purchases and $672.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeremy B. Hayden was on Nov 25, 2025, when they sold $362.4K worth of SGHT shares. This transaction involved 44,850 shares at $8.08 per share.
Jeremy B. Hayden currently owns 369,770 shares of CYTORI THERAPEUTICS, INC. (CYTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeremy B. Hayden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeremy B. Hayden has 27 Form 4 filings on record as an insider at CYTORI THERAPEUTICS, INC..
Set alerts for Jeremy B. Hayden and 40,000+ other insiders.